T. Peretz

发表

Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro.

E. Shiloni, O. Drize, S. Metzger, 1997, Metabolism: clinical and experimental.

BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression

D. Wiederschain, F. Nestle, Sharad K Sharma, 2022, Journal for ImmunoTherapy of Cancer.

Interleukin-6 secretion in mice is associated with reduced glucose-6-phosphatase and liver glycogen levels.

E. Shiloni, O. Drize, S. Metzger, 1997, The American journal of physiology.